The Government has been instructed to organise the passing of legislative acts setting forth the criteria for defining medicines as medicines produced in Russia, taking into account the laws in this area currently in effect in the Eurasian Economic Union.
Instructions to the Government also concern developing methods for evaluating demand for different medicines within Russia’s healthcare system, including with a view to import replacement; raising domestic production of life-saving and essential medicines to 90 percent of the Russian healthcare system’s needs; and drafting a list of medicines that Russia must be able to produce from the point of view of ensuring national security.
The Government was also instructed to draft proposals on using the results obtained through budget-funded research and development work in the area of producing medicines in order to organise industrial production of medicines using these new technologies.
A further instruction concerns the need to ensure ongoing production of medicines in the lower price segment on the list of life-saving and essential medicines, including through state regulation of maximum retail prices for these medicines.